ALKERMES | Nettoeinkommen

Net Income Veränderung Datum
AbbVie USD 822M 956M 2023-12
Acadia Pharmaceuticals USD 45.8M 110.97M 2023-12
ALKERMES USD 47.76M 189.31M 2023-09
Amgen USD 767M 963M 2023-12
Bristol-Myers Squibb USD 1.76B 166M 2023-12
Eli Lilly USD 2.19B 2.25B 2023-12
Gilead Sciences USD 1.43B 751M 2023-12
Intra Cellular Therapies USD -28579000 4.32M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Malin Corporation EUR 1.1M 10.6M 2023-06
Merck USD -1226000000 5.97B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Otsuka Holdings JPY 59.12B 17.96B 2023-09
Pfizer USD -3368000000 986M 2023-12
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



ALKERMES Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.